Academic Journal
Quartile not availableDiabetes Obesity and Metabolism
About Diabetes Obesity and Metabolism
About Diabetes Obesity and Metabolism
Diabetes Obesity and Metabolism is a peer-reviewed scholarly journal published by Wiley.
Key indicators: ISSN 14628902, 14631326.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
Publishing in Diabetes Obesity and Metabolism
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Diabetes Obesity and Metabolism?
14628902, 14631326.
Who publishes Diabetes Obesity and Metabolism?
Wiley.
Where do I submit to Diabetes Obesity and Metabolism?
Via the official website.
Is Diabetes Obesity and Metabolism peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Transition‐Specific Associations of Cardiometabolic Biomarker Burden With Cardio‐Renal‐Metabolic Multimorbidity Progression: A Multistate Cohort Study
Xiaoqing Li, Juan Peng, Jingjing Quan, Dongdong Zhang et al.
2026-10-14 · DOI: 10.1111/dom.71427GLP ‐1 Receptor Agonist Therapy Is Associated With Lower Risk of Lower Extremity Amputation in Adults With Type 2 Diabetes and Foot Ulcer Without Coded Peripheral Arterial Disease: A Hypothesis‐Generating Real‐World Cohort Study
Hani Robinson, Mustafa Yassin, Dror Robinson, Mohamad Eisa et al.
2026-10-14 · DOI: 10.1111/dom.71405The GLP ‐ 1R / GCGR Dual Agonist Mazdutide Attenuates Liver Steatosis and Decreases Circulating Cholesterol Levels in Mice With Metabolic Dysfunction‐Associated Steatotic Liver Disease
Lehan Yu, Guangyan Wang, Jingyi Zhang, Ming Liu et al.
2026-10-14 · DOI: 10.1111/dom.71435Reappraising the Role of GH / IGF ‐I Axis and β‐Cell Failure: Insights From Two Genetic Syndromes
Kevin C. J. Yuen, Alexandra Guevara, A. W. D. Gavilanes‐Jimenez, Enrique Teran et al.
2026-10-14 · DOI: 10.1111/dom.71386Real‐World Treatment Patterns and Weight Outcomes Before and After a Tirzepatide Price Increase in Over One Million Self‐Paying UK Adults With Overweight or Obesity
Sophie Dix, Anna Mulligan, Mattia Ficarelli, Edward Brooke et al.
2026-10-14 · DOI: 10.1111/dom.71410Safety, Tolerability, Pharmacokinetics and Exploratory Pharmacodynamics of Melanin‐Concentrating Hormone Receptor‐1 Antagonist RGH‐706 in Healthy and Overweight or Obese Men
Thomas Brevig, Borbála Szepes, Zsófia Borbála Dombi, Gabriella Magyar et al.
2026-10-14 · DOI: 10.1111/dom.71433The Effects of GLP ‐ 1RA ‐Based and SGLT2 Inhibitor Therapy on Perirenal Adipose Tissue in CKD Patients
Ana Checa‐Ros, Oscar Arias‐Mutis, Owahabanun‐Joshua Okojie, Pilar Salvador et al.
2026-10-13 · DOI: 10.1111/dom.71441SGLT2 Inhibitors Reduce Heart Failure Hospitalization, Cardiovascular Death and Kidney Outcomes in Type 2 Diabetes: A Meta‐Analysis of Randomized Controlled Trials
Ahmed Elbataa, Ahmed Mansour, Ahmed Elazab, Ammer Alabed et al.
2026-10-13 · DOI: 10.1111/dom.71411Does Survodutide Provide Renoprotection Beyond Its Metabolic and Haemodynamic Effects in Diabetic Kidney Disease?
Jiaxin He
2026-10-12 · DOI: 10.1111/dom.71446Diabetes and Family Out‐of‐Pocket Medical Spending Relative to Income Across Adult Age Groups in the United States
Hua Yang, Hua Li
2026-10-12 · DOI: 10.1111/dom.71440Acute Effects of Acarbose and Canagliflozin, Alone and in Combination, on Postprandial GLP ‐1 and Glycaemic Responses in Post‐Bariatric Hypoglycaemia: A Randomised Crossover Study
Wei Yang, Anna Kowalka, Lara Jimenez‐Pacheco, Veronica Greener et al.
2026-10-12 · DOI: 10.1111/dom.71420Glycaemic Management and Pregnancy Outcomes in HNF1A ‐ MODY
M. T. Crowley, P. McCluskey, N. Ng, B. Sanchez‐Lechuga et al.
2026-10-12 · DOI: 10.1111/dom.71416GLP ‐1 Receptor Agonists and Thromboembolic Risk in Patients With Atrial Fibrillation or Flutter and Type 2 Diabetes: A Propensity Score–Matched Cohort Study
Shao‐Wei Lo, Ting‐Wei Ernie Liao, Sai Prasad Ramachandran, Yung‐Fang Tu et al.
2026-10-12 · DOI: 10.1111/dom.71443Comparative Cardiorenal Efficacy and Safety of SGLT2 Inhibitors and Finerenone in Chronic Kidney Disease With Type 2 Diabetes: A Systematic Review and Network Meta‐Analysis
Fadi Alghzawi, Yousef Alghzawi, Leen Alhassan, Raghad Kiyyam et al.
2026-10-12 · DOI: 10.1111/dom.71434Autophagy Regulates Foxo1 Protein Abundance to Control Hepatic Glucose Production in Glucagon Signalling
Zheng Shen, Wanbao Yang, Quan Pan, Wen Jiang et al.
2026-10-09 · DOI: 10.1111/dom.71413Early Testing of a Mobile App‐Based Intervention to Support Body Weight Awareness and Monitoring in Pregnancy: A Randomised Controlled Feasibility Trial ( BUMP2.0 )
Moscho Michalopoulou, Stella J. P. Haffner, Susan A. Jebb, Lucy MacKillop et al.
2026-10-09 · DOI: 10.1111/dom.71426Polygenic Risk Scores for Islet Autoantibody Positive Early‐Stage Type 1 Diabetes Pre‐Screening
Jose Zapardiel‐Gonzalo, Christiane Winkler, Florian Haupt, Manja Jolink et al.
2026-10-09 · DOI: 10.1111/dom.71417GLP ‐1 Receptor Agonist Therapy for Glucocorticoid‐Induced Dysglycaemia: A Systematic Review
Aleksandra Jędrasek, Wiktoria Ulicka, Karolina Lisowska, Anna Fabiańska et al.
2026-10-08 · DOI: 10.1111/dom.71418Diabetes, Obesity and Metabolism
2026-11 · DOI: 10.1111/dom.71408Reviews
Community Reviews
Version History
October 10, 2026 at 6:10 pm
October 9, 2026